BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China

The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...

July 05, 2023 | News

Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

July 03, 2023 | News

Chime Biologics, Leads Biolabs, and BeiGene Join Forces to Advance LBL-007 mAb Globally

Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and provide clinical trial materials in China. BeiGe...

July 03, 2023 | News

Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D

This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...

June 29, 2023 | News

Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons

he tiny visual systems of flying insects have inspired researchers of the Hong Kong Polytechnic University (PolyU) to develop Optoelectronic Graded Neurons...

June 28, 2023 | News

SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza

SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...

June 27, 2023 | News

CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.

The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...

June 27, 2023 | News

HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.

OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...

June 27, 2023 | News

Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection

- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...

June 26, 2023 | News

Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693

Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...

June 26, 2023 | News

Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress

The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...

June 21, 2023 | News

AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 19, 2023 | News

Gilead Sciences Singapore Discusses Access and Affordability of CAR T-Cell Therapy in Singapore and Beyond

Can you elaborate on the current availability and accessibility of CAR T-cell therapies in Singapore? What are the key considerations or barriers that need...

June 19, 2023 | News

Chinese Medical Development Led by Hong Kong Dragon's Medical and Reproductive Giants

Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 at W Hong Kong, signing strategic partnership agreements with ...

June 12, 2023 | News

Stay Connected